Results for "epilepsy"
Conditions Encyclopedia Entry 1777484284
** This article provides an in-depth overview of **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT:** ### Overview Mitochondrial Myopathies (MM) are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which is separate from the DNA found in the cell's nucleus. Mitochondrial myopathies are characterized by muscle weakness, fatigue, and other symptoms that can vary in severity and impact daily life. The disorders are often inherited in an autosomal dominant or maternal pattern, meaning that a single copy of the mutated gene is enough to cause the condition, and it is passed down from mother to child. Mitochondrial myopathies are a heterogeneous group of disorders, with over 150 different mutations identified in the mitochondrial DNA. The most common forms of MM include **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**, **Kearns-Sayre Syndrome (KSS)**, and **Chronic Progressive External Ophthalmoplegia (CPEO)**. Each of these disorders has distinct symptoms and characteristics, but they all share a common underlying cause: damage to the mitochondria. ### History/Background The study of mitochondrial myopathies began in the 1960s, when researchers first identified the relationship between mitochondrial DNA mutations and muscle disease. Since then, advances in genetic testing and molecular biology have led to a greater understanding of the disorders and their underlying causes. In 1988, the first mitochondrial DNA mutation was identified in a patient with MERRF, marking a significant milestone in the field. Today, researchers continue to study mitochondrial myopathies, seeking to develop new treatments and improve the lives of those affected. ### Key Information Mitochondrial myopathies are characterized by a range of symptoms, including: * Muscle weakness and wasting * Fatigue and exercise intolerance * Eye movement disorders * Hearing loss * Cognitive impairment * Seizures and epilepsy The disorders can be inherited in an autosomal dominant or maternal pattern, and they often affect multiple family members. Diagnosis typically involves genetic testing, muscle biopsy, and imaging studies. Treatment options are limited, and management focuses on symptom relief and supportive care. ### Significance Mitochondrial myopathies are a significant public health concern, affecting an estimated 1 in 5,000 people worldwide. The disorders can have a profound impact on quality of life, causing significant disability and reducing life expectancy. Research into mitochondrial myopathies has also led to a greater understanding of the role of mitochondria in human disease, with implications for the study of other disorders, such as cancer and neurodegenerative disease. **INFOBOX:** - Name: Mitochondrial Myopathies - Type: Rare genetic disorder - Date: 1960s (first identified) - Location: Global - Known For: Unique genetic cause and complex symptoms **TAGS:** Mitochondrial myopathies, genetic disorders, muscle disease, rare diseases, mitochondrial DNA, genetic testing, molecular biology, exercise intolerance, eye movement disorders, hearing loss, cognitive impairment, seizures, epilepsy, supportive care, quality of life, public health concern, cancer, neurodegenerative disease.
Health & MedicineKetogenic Diet
The ketogenic diet is a high‑fat, adequate‑protein, low‑carbohydrate eating plan that induces metabolic ketosis and is medically employed, especially for refractory childhood epilepsy.
Health & MedicineConditions Encyclopedia Entry 1777585324
** This article provides a comprehensive overview of **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT:** ### Overview Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which is responsible for producing energy for the cell. Mitochondrial myopathies can affect various parts of the body, including the muscles, brain, and nervous system. Symptoms can vary widely, but often include muscle weakness, fatigue, and pain. In severe cases, mitochondrial myopathies can lead to life-threatening complications. Mitochondrial myopathies are often inherited in an **autosomal dominant** or **maternal inheritance** pattern, meaning that a single copy of the mutated gene is enough to cause the condition. This is because only egg cells contribute mitochondria to the fertilized egg, making mitochondrial DNA inherited solely from the mother. Mitochondrial myopathies can affect people of all ages, from infants to adults. ### History/Background The first reported cases of mitochondrial myopathies date back to the 1960s, when researchers identified a group of patients with **mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS)**. Since then, numerous other mitochondrial myopathies have been identified, including **myoclonic epilepsy with ragged-red fibers (MERRF)**, **neuropathy, ataxia, and retinitis pigmentosa (NARP)**, and **Leigh syndrome**. These disorders have been linked to mutations in various mitochondrial genes, including those involved in energy production, DNA replication, and protein synthesis. ### Key Information Mitochondrial myopathies are characterized by a range of symptoms, including: * Muscle weakness and wasting * Fatigue and exercise intolerance * Pain and cramping * Numbness and tingling * Vision loss and blindness * Hearing loss and deafness * Cognitive impairment and dementia * Seizures and epilepsy In addition to these symptoms, mitochondrial myopathies can also lead to life-threatening complications, such as: * Respiratory failure * Cardiac arrest * Seizure-induced status epilepticus * Stroke and cerebral edema ### Significance Mitochondrial myopathies are significant because they highlight the importance of mitochondrial function in maintaining cellular health. These disorders also underscore the need for early diagnosis and treatment to prevent life-threatening complications. Furthermore, research into mitochondrial myopathies has led to a greater understanding of the role of mitochondria in various diseases, including cancer, neurodegenerative disorders, and metabolic disorders. **INFOBOX:** - Name: Mitochondrial Myopathies - Type: Rare genetic disorders - Date: First reported cases in the 1960s - Location: Affects people worldwide - Known For: Rare genetic disorders affecting mitochondrial function **TAGS:** Mitochondrial myopathies, mitochondrial DNA, genetic disorders, muscle weakness, fatigue, pain, seizures, epilepsy, respiratory failure, cardiac arrest, cognitive impairment, dementia, vision loss, hearing loss, deafness.
Health & MedicineConditions Encyclopedia Entry 1781417106
** Condition 1781417106, also known as **Mitochondrial Myopathies**, is a group of rare genetic disorders characterized by muscle weakness and degeneration due to impaired mitochondrial function. **CONTENT:** ### Overview Mitochondrial Myopathies are a diverse group of conditions that affect the mitochondria, the energy-producing structures within cells. Mitochondrial myopathies are caused by mutations in mitochondrial DNA (mtDNA) or nuclear DNA (nDNA) that affect the function of the mitochondria. This impairment leads to a decrease in energy production, resulting in muscle weakness, fatigue, and other systemic symptoms. Mitochondrial myopathies can affect individuals of all ages, from infants to adults, and can be inherited in an autosomal dominant, autosomal recessive, or maternal pattern. ### History/Background The first descriptions of mitochondrial myopathies date back to the 1960s, when researchers identified a group of patients with muscle weakness and degeneration. However, it wasn't until the 1980s that the genetic basis of these conditions was understood. The discovery of mtDNA mutations in patients with mitochondrial myopathies led to a greater understanding of the role of mitochondria in energy production and the development of diagnostic tests for these conditions. Today, mitochondrial myopathies are recognized as a distinct group of disorders, with over 150 different mtDNA mutations identified. ### Key Information Mitochondrial myopathies can be classified into several subtypes, including: * **Kearns-Sayre Syndrome**: a rare condition characterized by progressive external ophthalmoplegia, muscle weakness, and cardiac conduction defects. * **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: a condition characterized by myoclonic seizures, muscle weakness, and ragged-red fibers on muscle biopsy. * **NARP Syndrome**: a condition characterized by neuropathy, ataxia, and retinitis pigmentosa. * **Leigh Syndrome**: a condition characterized by progressive brain degeneration, muscle weakness, and seizures. Symptoms of mitochondrial myopathies can vary widely depending on the subtype and individual affected. Common symptoms include: * Muscle weakness and fatigue * Muscle pain and cramping * Seizures and epilepsy * Vision loss and blindness * Hearing loss and deafness * Cardiac conduction defects and arrhythmias ### Significance Mitochondrial myopathies are significant because they highlight the importance of mitochondrial function in maintaining cellular energy production. Understanding the genetic basis of these conditions has led to the development of diagnostic tests and treatments, such as gene therapy and mitochondrial-targeted antioxidants. Additionally, research on mitochondrial myopathies has shed light on the role of mitochondria in aging and age-related diseases, such as Alzheimer's and Parkinson's. **INFOBOX:** - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** 1960s (first descriptions) - **Location:** Worldwide - **Known For:** Impaired mitochondrial function leading to muscle weakness and degeneration **TAGS:** Mitochondrial myopathies, genetic disorders, muscle weakness, fatigue, seizures, epilepsy, vision loss, hearing loss, cardiac conduction defects, gene therapy, mitochondrial-targeted antioxidants.
Health & MedicineConditions Encyclopedia Entry 1780592884
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT:** ## Overview Mitochondrial Myopathies (MM) are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are characterized by the accumulation of mutations in the mitochondrial DNA, leading to impaired energy production and subsequent damage to various tissues, particularly muscles. Mitochondrial Myopathies are often inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is enough to cause the condition. The symptoms of MM can vary widely, but often include muscle weakness, fatigue, and other systemic symptoms. Mitochondrial Myopathies are a complex and heterogeneous group of disorders, with over 150 different mutations identified in the mitochondrial DNA. The most common forms of MM include Myoclonic Epilepsy with Ragged-Red Fibers (MERRF), Kearns-Sayre Syndrome (KSS), and Chronic Progressive External Ophthalmoplegia (CPEO). Each of these conditions has distinct clinical features and prognoses, but all share a common underlying pathophysiology related to mitochondrial dysfunction. ## History/Background The first reported cases of Mitochondrial Myopathies date back to the 1960s, when a group of researchers identified a unique pattern of muscle damage in patients with myoclonic epilepsy. However, it wasn't until the 1980s that the underlying genetic cause of these disorders was identified. The discovery of the mitochondrial DNA and its role in energy production paved the way for a deeper understanding of the pathophysiology of MM. Since then, numerous studies have shed light on the molecular mechanisms underlying these disorders, leading to the development of new diagnostic and therapeutic strategies. ## Key Information Mitochondrial Myopathies are characterized by a range of clinical features, including: * Muscle weakness and wasting * Fatigue and exercise intolerance * Ophthalmoplegia (weakness of the eye muscles) * Epilepsy and seizures * Hearing loss and vision impairment * Cardiac conduction defects * Endocrine abnormalities The diagnosis of MM typically involves a combination of clinical evaluation, laboratory tests, and genetic analysis. Muscle biopsy is a key diagnostic tool, as it allows for the visualization of ragged-red fibers, a hallmark of mitochondrial myopathies. Genetic testing can identify the specific mutation responsible for the condition, which can inform prognosis and treatment decisions. ## Significance Mitochondrial Myopathies are a significant public health concern, affecting an estimated 1 in 5,000 individuals worldwide. While the exact prevalence of MM is unknown, it is estimated that over 100,000 people in the United States alone are affected by these disorders. The impact of MM on individuals and families cannot be overstated, as these disorders often result in significant disability, reduced quality of life, and increased healthcare costs. ## INFOBOX: - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** 1960s (first reported cases) - **Location:** Global - **Known For:** Rare genetic disorders affecting mitochondrial energy production ## TAGS: Mitochondrial Myopathies, genetic disorders, mitochondrial DNA, muscle weakness, fatigue, epilepsy, ophthalmoplegia, hearing loss, vision impairment, cardiology, endocrinology, genetic testing, muscle biopsy, ragged-red fibers.
Health & MedicineConditions Encyclopedia Entry 1780992267
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells, leading to muscle weakness and other systemic symptoms. ## Overview Mitochondrial Myopathies (MM) are a group of rare genetic disorders caused by mutations in the mitochondrial DNA (mtDNA). These disorders affect the mitochondria, the energy-producing structures within cells, leading to impaired energy production and subsequent damage to various tissues, particularly muscles. Mitochondrial myopathies are characterized by progressive muscle weakness, fatigue, and other systemic symptoms, which can significantly impact an individual's quality of life. The disorders are often inherited in an autosomal dominant or maternal pattern, meaning they can be passed down from a parent or inherited from a mother. Mitochondrial myopathies are a diverse group of disorders, with over 150 different mutations identified in the mitochondrial DNA. The most common forms of MM include **Myoclonus Epilepsy with Ragged-Red Fibers (MERRF)**, **Kearns-Sayre Syndrome (KSS)**, and **Chronic Progressive External Ophthalmoplegia (CPEO)**. Each of these disorders has distinct clinical features, but they all share a common underlying defect in mitochondrial energy production. ## History/Background The first reported cases of mitochondrial myopathies date back to the 1960s, when researchers began to describe a group of patients with progressive muscle weakness and other systemic symptoms. In the 1980s, the discovery of mitochondrial DNA mutations revolutionized the field of mitochondrial research, allowing scientists to identify the genetic basis of these disorders. Since then, numerous studies have shed light on the molecular mechanisms underlying mitochondrial myopathies, leading to a better understanding of these complex disorders. ## Key Information Mitochondrial myopathies are characterized by a range of clinical features, including: * Progressive muscle weakness and fatigue * Muscle wasting and atrophy * Ophthalmoplegia (weakness of the eye muscles) * Epilepsy and seizures * Hearing loss and vision impairment * Cardiac conduction defects * Endocrine disorders The diagnosis of mitochondrial myopathies typically involves a combination of clinical evaluation, laboratory tests, and genetic analysis. Muscle biopsy and mitochondrial DNA sequencing are essential tools in the diagnosis of these disorders. Treatment options for MM are limited, and management is often focused on symptom relief and supportive care. ## Significance Mitochondrial myopathies are a significant public health concern, affecting an estimated 1 in 5,000 individuals worldwide. These disorders have a profound impact on an individual's quality of life, causing significant disability and premature mortality. Research into mitochondrial myopathies has led to a greater understanding of the molecular mechanisms underlying these disorders, paving the way for the development of novel therapeutic strategies. INFOBOX: - **Name:** Mitochondrial Myopathies - **Type:** Rare genetic disorders - **Date:** First reported cases in the 1960s - **Location:** Global prevalence - **Known For:** Progressive muscle weakness and impaired energy production TAGS: Mitochondrial myopathies, rare genetic disorders, mitochondrial DNA, muscle weakness, fatigue, ophthalmoplegia, epilepsy, hearing loss, vision impairment, cardiac conduction defects, endocrine disorders, muscle biopsy, genetic analysis, treatment options, supportive care.